These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 6851086)
1. Measurement of true salicylate concentrations in serum from patients with Reye's syndrome. Kang ES; Todd TA; Capaci MT; Schwenzer K; Jabbour JT Clin Chem; 1983 Jun; 29(6):1012-4. PubMed ID: 6851086 [TBL] [Abstract][Full Text] [Related]
2. Serum salicylate concentrations in Reye's disease. A study of 130 biopsy-proven cases. Partin JS; Partin JC; Schubert WK; Hammond JG Lancet; 1982 Jan; 1(8265):191-4. PubMed ID: 6119559 [TBL] [Abstract][Full Text] [Related]
3. Reye's syndrome in the United States from 1981 through 1997. Belay ED; Bresee JS; Holman RC; Khan AS; Shahriari A; Schonberger LB N Engl J Med; 1999 May; 340(18):1377-82. PubMed ID: 10228187 [TBL] [Abstract][Full Text] [Related]
4. Confirmation of serum salicylate levels in Reye's syndrome: a comparison between the Natelson colorimetric method and high performance liquid chromatography. Clark JH; Nagamori K; Fitzgerald JF Clin Chim Acta; 1985 Feb; 145(3):243-7. PubMed ID: 3987027 [TBL] [Abstract][Full Text] [Related]
5. Public Health Service study of Reye's syndrome and medications. Report of the main study. Hurwitz ES; Barrett MJ; Bregman D; Gunn WJ; Pinsky P; Schonberger LB; Drage JS; Kaslow RA; Burlington DB; Quinnan GV JAMA; 1987 Apr; 257(14):1905-11. PubMed ID: 3820509 [TBL] [Abstract][Full Text] [Related]
6. Salicylate and mitochondrial monoamine oxidase function in Reye's syndrome. Faraj BA; Caplan D; Lolies P; Buchanan C J Pharm Sci; 1987 Jun; 76(6):423-6. PubMed ID: 3625483 [TBL] [Abstract][Full Text] [Related]
7. A comparison of liver ultrastructure in salicylate intoxication and Reye's syndrome. Partin JS; Daugherty CC; McAdams AJ; Partin JC; Schubert WK Hepatology; 1984; 4(4):687-90. PubMed ID: 6745858 [TBL] [Abstract][Full Text] [Related]
12. [Reye's syndrome--a severe complication of salicylate therapy]. Vengerovskiĭ AI; Baturina NO; Saratikov AS Eksp Klin Farmakol; 2000; 63(2):76-80. PubMed ID: 10834102 [TBL] [Abstract][Full Text] [Related]
13. Is aspirin a cause of Reye's syndrome? A case against. Orlowski JP; Hanhan UA; Fiallos MR Drug Saf; 2002; 25(4):225-31. PubMed ID: 11994026 [TBL] [Abstract][Full Text] [Related]
15. Reye's syndrome: a case control study of medication use and associated viruses in Australia. Orlowski JP; Campbell P; Goldstein S Cleve Clin J Med; 1990 Jun; 57(4):323-9. PubMed ID: 2364532 [TBL] [Abstract][Full Text] [Related]
16. The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls. Glasgow JF; Middleton B; Moore R; Gray A; Hill J Biochim Biophys Acta; 1999 May; 1454(1):115-25. PubMed ID: 10354521 [TBL] [Abstract][Full Text] [Related]
17. Reye's syndrome associated with long-term aspirin therapy. Young RS; Torretti D; Williams RH; Hendriksen D; Woods M JAMA; 1984 Feb; 251(6):754-6. PubMed ID: 6694278 [TBL] [Abstract][Full Text] [Related]
18. [Reye's syndrome in an adult following therapy with salicylates in Still's disease]. Tumiati B; Azzalito C; Veneziani M Medicina (Firenze); 1989; 9(1):64-5. PubMed ID: 2739536 [TBL] [Abstract][Full Text] [Related]
19. Salicylates, nitric oxide, malaria, and Reye's syndrome. Clark I; Whitten R; Molyneux M; Taylor T Lancet; 2001 Feb; 357(9256):625-7. PubMed ID: 11558501 [TBL] [Abstract][Full Text] [Related]
20. Hepatic and encephalopathic components of Reye's syndrome: factor analysis of admission data from 209 patients. Mitchell RA; Partin JC; Partin JS; Ram ML Neurology; 1985 Aug; 35(8):1236-9. PubMed ID: 4022364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]